Brain imaging

Recent articles

Conference attendees.

Reporter’s notebook: Highlights from INSAR 2026

At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.

By Diana Kwon
30 April 2026 | 6 min read
Research image of lesion network mapping.

‘Overdue’ debate unfurls over neuroimaging method

After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.

By Angie Voyles Askham
17 April 2026 | 8 min read
A computer cursor hovers over distorted data.

Neuroscientists challenge NIH’s proposed human-data access policy

The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.

By Claudia López Lloreda
17 March 2026 | 5 min read

Large-scale neuroimaging datasets often lack information specific to women’s health, constraining AI’s analysis potential

Addressing this gap will require collecting widespread data on pregnancy, menopause and other life events women experience—and could bring us closer to the “holy grail” of linking brain and behavior.

By Amy Kuceyeski
16 March 2026 | 0 min watch

How insights from network theory can boost interdisciplinary efforts

Communication on one interdisciplinary research team improved after the researchers turned an analysis technique used to study the brain on themselves and identified the roles people played in lab meetings.

By Emily Singer
23 February 2026 | 0 min watch
A stack of paper topped by bits of shredded paper.

NIH scraps policy that classified basic research in people as clinical trials

The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.

By Calli McMurray
3 February 2026 | 6 min read
Researcher Russell Poldrack's face closeup, with a scanner seen out of focus behind him.

A brief history of precision self-scanning

When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.

By Lauren Gravitz
21 January 2026 | 13 min read
Brain network maps creating using lesion network mapping.

Methodological flaw may upend network mapping tool

The lesion network mapping method, used to identify disease-specific brain networks for clinical stimulation, produces a nearly identical network map for any given condition, according to a new study.

By Angie Voyles Askham
15 January 2026 | 7 min read
Portion of The Transmitter’s state of neuroscience semantic map.

Putting 50 years of neuroscience on the map

Navigate the rise and fall of research topics over five decades using our interactive map, which is based on a semantic analysis of nearly 350,000 abstracts in leading neuroscience journals.

By The Transmitter
15 November 2025 | 3 min read
Two bouncing balls.

What are the fastest-growing areas in neuroscience?

Respondents pointed to computational neuroscience, systems neuroscience, neuroimmunology and neuroimaging, among other subfields.

By The Transmitter
15 November 2025 | 6 min read

Explore more from The Transmitter

Headshots of Yale researchers Yong-Hui Jiang and Jiangbing Zhou.

Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions

Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.

By Natalia Mesa
3 June 2026 | 11 min read

What counts as a ‘naturalistic’ behavior?

Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.

By Paul Middlebrooks
3 June 2026 | 1 min read
Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read